iBio, Inc. (62) | Business Operations (9)
Browse by Subcategory
Recent Contracts
-
Form of Irrevocable Proxy For Voting Control
(Filed With SEC on May 12, 2022)
-
Confidential Settlement and Mutual Release with Fraunhofer USA, Inc. dated May 4, 2021
(Filed With SEC on September 28, 2021)
-
Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc
(Filed With SEC on August 27, 2021)
-
Indemnification Agreement by and between iBio, Inc., John Delta and TechCXO, LLC dated July 13, 2020
(Filed With SEC on October 5, 2020)
-
Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd
(Filed With SEC on March 19, 2020)
-
Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc
(Filed With SEC on August 27, 2021)
-
Second Amended and Restated Voting Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors
(Filed With SEC on August 27, 2021)
-
Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd
(Filed With SEC on March 13, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on April 1, 2019)